Startup Uses Microscopy Breakthrough to Speed Creation of COVID-19 Vaccines

In the global race to tame the spread of COVID-19, scientific researchers and pharmaceutical companies first must understand the virus’s protein structure. Doing so requires building detailed 3D models of protein molecules, which until recently has been an intensely time-consuming task. Structura Biotechnology’s groundbreaking software is helping speed things along.